A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

Lee Brennan says childhood cancer left him infertile - Brennan, who was diagnosed with cancer twice as a child, also shared ...

New combination therapy will be available on the NHS, offering new hope to people with advanced Hodgkin lymphoma ...

NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.

Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.

A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to acquire the latter’s investigational bispecific antibody DR-0201.

The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system ...

FAYETTE - Doris Irene (Hodgkins) Morris, 85, of Fayette, passed away peacefully on Feb. 16, 2025, at the Augusta Center for ... FAYETTE – Doris Irene (Hodgkins) Morris, 85, of Fayette, passed ...

Although there is no cure, diabetic retinal disease treatment has improved over the past two decades. Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in ...